<DOC>
	<DOCNO>NCT02974933</DOCNO>
	<brief_summary>The purpose study evaluate efficacy apatinib mesylate combine pemetrexed alone advanced non-small cell lung cancer patient second second line treatment progression-free survival</brief_summary>
	<brief_title>Apatinib Mesylate Combined With Pemetrexed Treatment Pretreated Advanced Non-squamous Non-small Cell Lung Cancer</brief_title>
	<detailed_description>It one-arm study . The progression-free survival evaluate .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Pemetrexed</mesh_term>
	<criteria>1 . Aged 18 year 70years . 2 . Histologically cytologically confirm nonsquamous nonsmall cell lung cancer ( stage IIIB/IV ) . 3 . Measurable lesion define RECIST criterion . 4 . Locally advanced lung cancer treat surgery , recurrent metastatic lung cancer 5 . ECOG performance status ( PS ) 0 1 . 6 . Life expectancy ≥3 month . 7 . Informed consent . 1 . Squamous carcinoma ( include adenosquamous carcinoma ) , small cell lung cancer . 2 . Newly diagnosed Central Nervous System ( CNS ) metastases yet definitively treat surgery and/or radiation . 3 . Tumor invade big vessel close big vessel ( less 5mm ) 4 . Obvious cavity necrosis form tumor 5 . Uncontrolled hypertension 6 . Myocardial ischemia infarction stage II , cardiac insufficiency . 7 . Abnormal coagulation ( INR &gt; 1.5 PT &gt; ULN+4 , APTT &gt; 1.5 ULN ) , bleed tendency receive coagulation therapy 8 . The active HBV HCV infection 9 . History malignancy except cure basal cell carcinoma skin carcinoma insitu uterine cervix . 10 . Hemoptysis , 2.5ml daily 11 . Thrombosis 12 month , include pulmonary thrombosis , stoke , deep venous thrombosis . 12 . Unhealed bone fracture wound long time 13 . Received big surgery , bone fracture ulcer 4 week . 14 . Urine protein≥++ , urine protein 24 hours≥1.0g 15 . Use CYP3A4 inhibitor within 7 day CYP3A4 inducer within 12 day prior enrollment 16 . Have receive prior treatment VEGFR TKI ( Bevacizumab permit ) . 17 . Pregnant lactate woman , woman unwilling practice contraception study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>apatinib</keyword>
	<keyword>pemetrexed</keyword>
	<keyword>NSCLC</keyword>
</DOC>